Skip to content
Search

Latest Stories

Women’s health startup pulls in £4.2m in seed funding

A women's health startup has secured multi-million pound investment to "revolutionise" reproductive health.

Hertility Health has raised £4.2m in seed funding in a round led by UK seed investor LocalGlobe, Venrex and some key angel investors, including former Bupa boss Evelyn Bourke, and CEO of Nested and GoCardless Matt Robinson.


The company was founded in 2020 by scientists Dr Helen O’Neill, Dr Natalie Getreu and Deirdre O’Neill -- while on their maternity leave -- during the pandemic. According to them, Hertility Health addresses one of the biggest market segments in which there has been little advancement for many years.

It specialises in reducing diagnosis times for women’s health issues such as endometriosis and polycyctic ovarian syndrome (PCOS).

The investment will help Hertility Health expand its current product offering of fertility and hormone testing, menopause, miscarriage, postnatal care, PCOS and endometriosis testing, as well as aid the expansion of its current clinical trials which aim to reduce diagnosis time for conditions and firm up the company's position as a scientific and clinical educational health hub for women.

CEO O’Neill said: “Some of the women spend over ten years on their contraception, never being fully aware that there might be something wrong. On an average, one in five Hertility Health users were found to have a previously undiagnosed reproductive condition which has been revealed as a result of testing with Hertility Health.”

Julia Hawkins from LocalGlobe said: “Together, we’re excited to help Hertility Health become the home for women’s health, building on its  success to date and meeting the clear consumer demand for an accessible, affordable, high-quality solution to reproductive health concerns and curiosity.”

Mark Esiri of Venrex Investment Management, said: “Venrex tries to find creative entrepreneurs who often have ‘differences of opinion’ with the status quo. This has been a common thread at companies we have been lucky enough to back, including Revolut, Charlotte Tilbury, Mumsnet, NotOnTheHighStreet and Maven Clinic. We are very fortunate to be working with the Hertility Health team who are bringing world class technical expertise, a data-driven approach and relentless energy to address deeply important health issues. We believe that the founders will use their expertise to positively change the world.”

So far, the start up has helped over 2,000 women understand their reproductive health and infertility risks, offering fertility counselling to those in need.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less